Sfoglia per Autore
Metronomic cyclophosphamide in elderly patients with advanced, castration-resistant prostate cancer
2010-01-01 Fontana, A; Bocci, Guido; Galli, L; D'Arcangelo, M; Derosa, L; Fioravanti, Anna; Orlandi, Paola; Barletta, Mt; Landi, L; Bursi, S; Minuti, G; Bona, E; Grazzini, I; Danesi, Romano; Falcone, Alfredo
Pilot study of correlation between single nucleotide polymorphisms (SNPS) of pro-and anti-angiogenic genes and response to bevacizumab (BV) plus chemotherapy (CT) in patients with metastatic breast cancer (MBC)
2011-01-01 Allegrini, G; Bocci, Guido; Fontana, A; Amoroso, D; Ferro, A; Giuntini, N; Casadei, V; DI LIETO, M; Marcucci, L; Pazzagli, I; Coltelli, L; Lucchesi, S; Arrighi, M; Scalese, M; Camerini, A; Orlandi, P; Bona, E; Villa, F; DI PASQUALE, M; Falcone, Alfredo
Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo.
2011-01-01 B., Canu; Fioravanti, Anna; Orlandi, Paola; DI DESIDERO, Teresa; G., Alì; Fontanini, Gabriella; DI PAOLO, Antonello; M. D., Tacca; Danesi, Romano; Bocci, Guido
Antiproliferative and proapoptotic activity of CLM3, a novel multiple tyrosine kinase inhibitor, alone and in combination with SN-38 on endothelial and cancer cells
2011-01-01 Bocci, Guido; Fioravanti, Anna; LA MOTTA, Concettina; Orlandi, Paola; Canu, B.; DI DESIDERO, Teresa; Mugnaini, L.; Sartini, S.; Cosconati, S.; Frati, R.; Antonelli, Alessandro; Berti, Piero; Miccoli, Paolo; DA SETTIMO PASSETTI, Federico; Danesi, Romano
Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer
2011-01-01 Loupakis, F.; Cremolini, Chiara; Fioravanti, A.; Orlandi, P.; Salvatore, L.; Masi, G.; DI DESIDERO, T.; Canu, B.; Schirripa, M.; Frumento, P.; DI PAOLO, Antonello; Danesi, Romano; Falcone, Alfredo; Bocci, Guido
Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers
2012-01-01 Allegrini, G; Di Desidero, T; Barletta, Mt; Fioravanti, A; Orlandi, P; Canu, B; Chericoni, S; Loupakis, F; DI PAOLO, Antonello; Masi, G; Fontana, A; Lucchesi, S; Arrighi, G; Giusiani, Mario; Ciarlo, A; Brandi, G; Danesi, Romano; Kerbel, Rs; Falcone, Alfredo; Bocci, Guido
Polymorphisms interaction to predict bevacizumab (BV) efficacy in metastatic breast cancer (MBC) patients: an exploratory retrospective analysis.
2012-01-01 Allegrini, G; Bocci, Guido; Fontana, A; Goletti, O; Camerini, A; Galligioni, E; Ferro, A; Giuntini, N; Casadei, V; Cazzaniga, M; Fiorentini, G; DI LIETO, M; Marcucci, L; Pazzagli, I; Coltelli, L; Lucchesi, S; Finale, C; Bona, E; Scalese, M; Orlandi, P; Villa, F; Morini, S; Amoroso, D; Arrighi, G; Filidei, M; DI PASQUALE, M; Falcone, Alfredo
Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration.
2012-01-01 Agosta, E.; Lazzeri, S.; Orlandi, Paola; Figus, M.; Fioravanti, Anna; DI DESIDERO, Teresa; Sartini, M. S.; Nardi, Marco; Danesi, Romano; Bocci, Guido
First-line metronomic chemotherapy in a metastatic model of spontaneous canine tumours: a pilot study
2012-01-01 Marchetti, Veronica; Giorgi, Mario; Fioravanti, A; Finotello, R; Citi, Simonetta; Canu, B; Orlandi, P; DI DESIDERO, T; Danesi, Romano; Bocci, Guido
Metronomic ceramide analogs inhibit angiogenesis in pancreatic cancer through up-regulation of caveolin-1 and thrombospondin-1 and down-regulation of cyclin D1
2012-01-01 Bocci, Guido; Fioravanti, Anna; Orlandi, Paola; DI DESIDERO, Teresa; Natale, Gianfranco; Fanelli, G; Viacava, P; Naccarato, ANTONIO GIUSEPPE; Francia, G; Danesi, Romano
The rs2071559 AA VEGFR-2 genotype frequency is significantly lower in neovascular age-related macular degeneration patients.
2012-01-01 Lazzeri, S.; Orlandi, Paola; Figus, M.; Fioravanti, Anna; Cascio, E.; DI DESIDERO, Teresa; Agosta, E.; Canu, B.; Sartini, M. S.; Danesi, Romano; Nardi, Marco; Bocci, Guido
Polymorphisms interaction to predict bevacizumab (BV) efficacy in metastatic breast cancer (MBC) patients (pts): An exploratory retrospective analysis.
2013-01-01 Coltelli, L; Fontana, A; Bocci, Guido; Camerini, A; Ferro, A; Cazzaniga, M. E.; Casadei, V; Pazzaglia, I; Marcucci, L; Allegrini, G; Lucchesi, S; Bona, E; Scalese, M; Orlandi, P; Villa, F; Morini, S; Amoroso, D; Arrighi, G; Filidei, M; Falcone, Alfredo
Metronomic capecitabine (cape) and cyclophosphamide (CTX) for refractory metastatic colorectal cancer (mCRC): Results of a phase II trial.
2013-01-01 Marmorino, F; Cremolini, Chiara; Loupakis, F; Salvatore, L; Schirripa, M; Antoniotti, C; DI DESIDERO, T; Canu, B; Orlandi, P; Fioravanti, A; Masi, G; Bocci, Guido; Falcone, Alfredo
Circulating angiogenic factors as predictors of benefit from bevacizumab (bev) beyond progression in metastatic colorectal cancer (mCRC): Translational analyses from the phase III BEBYP trial.
2013-01-01 Cremolini, Chiara; Loupakis, F; Bocci, Guido; Fioravanti, A; Masi, G; Salvatore, L; Marmorino, F; Orlandi, P; Schirripa, M; DI DESIDERO, T; Antoniotti, C; Canu, B; Danesi, Romano; Falcone, Alfredo
Prospective analysis of the early modulation of plasma amphiregulin (AR) during treatment with cetuximab and irinotecan in irinotecan-refractory metastatic colorectal cancer (mCRC) patients (pts).
2013-01-01 Cremolini, Chiara; Loupakis, F; Antoniotti, C; Fioravanti, A; Orlandi, P; Salvatore, L; Canu, B; Schirripa, M; Masi, G; DI DESIDERO, T; Marmorino, F; Bergamo, F; Zoratto, F; Bocci, Guido; Falcone, Alfredo
VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide.
2013-01-01 Orlandi, Paola; A., Fontana; Fioravanti, Anna; DI DESIDERO, Teresa; L., Galli; L., Derosa; B., Canu; R., Marconcini; E., Biasco; Solini, Anna; G., Francia; Danesi, Romano; Falcone, Alfredo; Bocci, Guido
VEGF-A polymorphisms predict short-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration
2013-01-01 Lazzeri, S; Figus, M; Orlandi, Paola; Fioravanti, Anna; DI DESIDERO, Teresa; Agosta, E; Sartini, Ms; Posarelli, Chiara; Nardi, Marco; Danesi, Romano; Bocci, Guido
Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1.
2013-01-01 DI DESIDERO, Teresa; Fioravanti, Anna; Orlandi, Paola; B., Canu; Giannini, Riccardo; Borrelli, Nicla; S., Man; P., Xu; Fontanini, Gabriella; Basolo, Fulvio; R. S., Kerbel; G., Francia; Danesi, Romano; Bocci, Guido
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo
2014-01-01 Antonelli, Alessandro; Bocci, Guido; LA MOTTA, Concettina; Ferrari, Sm; Fallahi, P; Corrado, A; Fioravanti, Anna; Sartini, Stefania; Orlandi, Paola; Piaggi, S; Corti, Alessandro; Materazzi, Gabriele; Galleri, D; Ulisse, S; Fontanini, Gabriella; Danesi, Romano; DA SETTIMO PASSETTI, Federico; Miccoli, Paolo
Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies.
2014-01-01 Sartini, Stefania; Coviello, Vito; Bruno, A; La Pietra, V; Marinelli, L; Simorini, Francesca; Taliani, Sabrina; Salerno, Silvia; Marini, ANNA MARIA; Fioravanti, Anna; Orlandi, Paola; Antonelli, Alessandro; DA SETTIMO PASSETTI, Federico; Novellino, E; Bocci, Guido; LA MOTTA, Concettina
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Metronomic cyclophosphamide in elderly patients with advanced, castration-resistant prostate cancer | 1-gen-2010 | Fontana, A; Bocci, Guido; Galli, L; D'Arcangelo, M; Derosa, L; Fioravanti, Anna; Orlandi, Paola; Barletta, Mt; Landi, L; Bursi, S; Minuti, G; Bona, E; Grazzini, I; Danesi, Romano; Falcone, Alfredo | |
| Pilot study of correlation between single nucleotide polymorphisms (SNPS) of pro-and anti-angiogenic genes and response to bevacizumab (BV) plus chemotherapy (CT) in patients with metastatic breast cancer (MBC) | 1-gen-2011 | Allegrini, G; Bocci, Guido; Fontana, A; Amoroso, D; Ferro, A; Giuntini, N; Casadei, V; DI LIETO, M; Marcucci, L; Pazzagli, I; Coltelli, L; Lucchesi, S; Arrighi, M; Scalese, M; Camerini, A; Orlandi, P; Bona, E; Villa, F; DI PASQUALE, M; Falcone, Alfredo | |
| Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo. | 1-gen-2011 | B., Canu; Fioravanti, Anna; Orlandi, Paola; DI DESIDERO, Teresa; G., Alì; Fontanini, Gabriella; DI PAOLO, Antonello; M. D., Tacca; Danesi, Romano; Bocci, Guido | |
| Antiproliferative and proapoptotic activity of CLM3, a novel multiple tyrosine kinase inhibitor, alone and in combination with SN-38 on endothelial and cancer cells | 1-gen-2011 | Bocci, Guido; Fioravanti, Anna; LA MOTTA, Concettina; Orlandi, Paola; Canu, B.; DI DESIDERO, Teresa; Mugnaini, L.; Sartini, S.; Cosconati, S.; Frati, R.; Antonelli, Alessandro; Berti, Piero; Miccoli, Paolo; DA SETTIMO PASSETTI, Federico; Danesi, Romano | |
| Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer | 1-gen-2011 | Loupakis, F.; Cremolini, Chiara; Fioravanti, A.; Orlandi, P.; Salvatore, L.; Masi, G.; DI DESIDERO, T.; Canu, B.; Schirripa, M.; Frumento, P.; DI PAOLO, Antonello; Danesi, Romano; Falcone, Alfredo; Bocci, Guido | |
| Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers | 1-gen-2012 | Allegrini, G; Di Desidero, T; Barletta, Mt; Fioravanti, A; Orlandi, P; Canu, B; Chericoni, S; Loupakis, F; DI PAOLO, Antonello; Masi, G; Fontana, A; Lucchesi, S; Arrighi, G; Giusiani, Mario; Ciarlo, A; Brandi, G; Danesi, Romano; Kerbel, Rs; Falcone, Alfredo; Bocci, Guido | |
| Polymorphisms interaction to predict bevacizumab (BV) efficacy in metastatic breast cancer (MBC) patients: an exploratory retrospective analysis. | 1-gen-2012 | Allegrini, G; Bocci, Guido; Fontana, A; Goletti, O; Camerini, A; Galligioni, E; Ferro, A; Giuntini, N; Casadei, V; Cazzaniga, M; Fiorentini, G; DI LIETO, M; Marcucci, L; Pazzagli, I; Coltelli, L; Lucchesi, S; Finale, C; Bona, E; Scalese, M; Orlandi, P; Villa, F; Morini, S; Amoroso, D; Arrighi, G; Filidei, M; DI PASQUALE, M; Falcone, Alfredo | |
| Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration. | 1-gen-2012 | Agosta, E.; Lazzeri, S.; Orlandi, Paola; Figus, M.; Fioravanti, Anna; DI DESIDERO, Teresa; Sartini, M. S.; Nardi, Marco; Danesi, Romano; Bocci, Guido | |
| First-line metronomic chemotherapy in a metastatic model of spontaneous canine tumours: a pilot study | 1-gen-2012 | Marchetti, Veronica; Giorgi, Mario; Fioravanti, A; Finotello, R; Citi, Simonetta; Canu, B; Orlandi, P; DI DESIDERO, T; Danesi, Romano; Bocci, Guido | |
| Metronomic ceramide analogs inhibit angiogenesis in pancreatic cancer through up-regulation of caveolin-1 and thrombospondin-1 and down-regulation of cyclin D1 | 1-gen-2012 | Bocci, Guido; Fioravanti, Anna; Orlandi, Paola; DI DESIDERO, Teresa; Natale, Gianfranco; Fanelli, G; Viacava, P; Naccarato, ANTONIO GIUSEPPE; Francia, G; Danesi, Romano | |
| The rs2071559 AA VEGFR-2 genotype frequency is significantly lower in neovascular age-related macular degeneration patients. | 1-gen-2012 | Lazzeri, S.; Orlandi, Paola; Figus, M.; Fioravanti, Anna; Cascio, E.; DI DESIDERO, Teresa; Agosta, E.; Canu, B.; Sartini, M. S.; Danesi, Romano; Nardi, Marco; Bocci, Guido | |
| Polymorphisms interaction to predict bevacizumab (BV) efficacy in metastatic breast cancer (MBC) patients (pts): An exploratory retrospective analysis. | 1-gen-2013 | Coltelli, L; Fontana, A; Bocci, Guido; Camerini, A; Ferro, A; Cazzaniga, M. E.; Casadei, V; Pazzaglia, I; Marcucci, L; Allegrini, G; Lucchesi, S; Bona, E; Scalese, M; Orlandi, P; Villa, F; Morini, S; Amoroso, D; Arrighi, G; Filidei, M; Falcone, Alfredo | |
| Metronomic capecitabine (cape) and cyclophosphamide (CTX) for refractory metastatic colorectal cancer (mCRC): Results of a phase II trial. | 1-gen-2013 | Marmorino, F; Cremolini, Chiara; Loupakis, F; Salvatore, L; Schirripa, M; Antoniotti, C; DI DESIDERO, T; Canu, B; Orlandi, P; Fioravanti, A; Masi, G; Bocci, Guido; Falcone, Alfredo | |
| Circulating angiogenic factors as predictors of benefit from bevacizumab (bev) beyond progression in metastatic colorectal cancer (mCRC): Translational analyses from the phase III BEBYP trial. | 1-gen-2013 | Cremolini, Chiara; Loupakis, F; Bocci, Guido; Fioravanti, A; Masi, G; Salvatore, L; Marmorino, F; Orlandi, P; Schirripa, M; DI DESIDERO, T; Antoniotti, C; Canu, B; Danesi, Romano; Falcone, Alfredo | |
| Prospective analysis of the early modulation of plasma amphiregulin (AR) during treatment with cetuximab and irinotecan in irinotecan-refractory metastatic colorectal cancer (mCRC) patients (pts). | 1-gen-2013 | Cremolini, Chiara; Loupakis, F; Antoniotti, C; Fioravanti, A; Orlandi, P; Salvatore, L; Canu, B; Schirripa, M; Masi, G; DI DESIDERO, T; Marmorino, F; Bergamo, F; Zoratto, F; Bocci, Guido; Falcone, Alfredo | |
| VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide. | 1-gen-2013 | Orlandi, Paola; A., Fontana; Fioravanti, Anna; DI DESIDERO, Teresa; L., Galli; L., Derosa; B., Canu; R., Marconcini; E., Biasco; Solini, Anna; G., Francia; Danesi, Romano; Falcone, Alfredo; Bocci, Guido | |
| VEGF-A polymorphisms predict short-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration | 1-gen-2013 | Lazzeri, S; Figus, M; Orlandi, Paola; Fioravanti, Anna; DI DESIDERO, Teresa; Agosta, E; Sartini, Ms; Posarelli, Chiara; Nardi, Marco; Danesi, Romano; Bocci, Guido | |
| Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1. | 1-gen-2013 | DI DESIDERO, Teresa; Fioravanti, Anna; Orlandi, Paola; B., Canu; Giannini, Riccardo; Borrelli, Nicla; S., Man; P., Xu; Fontanini, Gabriella; Basolo, Fulvio; R. S., Kerbel; G., Francia; Danesi, Romano; Bocci, Guido | |
| CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo | 1-gen-2014 | Antonelli, Alessandro; Bocci, Guido; LA MOTTA, Concettina; Ferrari, Sm; Fallahi, P; Corrado, A; Fioravanti, Anna; Sartini, Stefania; Orlandi, Paola; Piaggi, S; Corti, Alessandro; Materazzi, Gabriele; Galleri, D; Ulisse, S; Fontanini, Gabriella; Danesi, Romano; DA SETTIMO PASSETTI, Federico; Miccoli, Paolo | |
| Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies. | 1-gen-2014 | Sartini, Stefania; Coviello, Vito; Bruno, A; La Pietra, V; Marinelli, L; Simorini, Francesca; Taliani, Sabrina; Salerno, Silvia; Marini, ANNA MARIA; Fioravanti, Anna; Orlandi, Paola; Antonelli, Alessandro; DA SETTIMO PASSETTI, Federico; Novellino, E; Bocci, Guido; LA MOTTA, Concettina |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile